With dramatic changes in lifestyles over the last 20 years, nonalcoholic fatty liver disease
(NAFLD) has become the most prevalent liver disorder in China but has not received …

The global epidemiology of hepatitis D is changing with the widespread implementation of
vaccination against hepatitis B. In high-income countries that achieved optimal control of …

Background & Aims Chronic hepatitis D (CHD) is the most severe form of chronic viral
hepatitis but its role in the development of hepatocellular carcinoma (HCC) remains …

Background & Aims HDV infection causes severe chronic liver disease in individuals
infected with HBV. However, the factors associated with poor prognosis are largely …

Hepatitis delta virus (HDV) is a defective virus and a satellite of the hepatitis B virus (HBV).
Its RNA genome is unique among animal viruses, but it shares common features with some …

Interferon alpha is the only treatment option for hepatitis delta virus (HDV). Trials
investigating the efficacy of pegylated interferon alpha (PEG‐IFNa) showed HDV RNA …

Hepatitis D is caused by the hepatitis D virus (HDV), a unique RNA pathogen that requires
the hepatitis B surface antigen (HBsAg) to infect. Hepatitis D is transmitted by the parenteral …

Chronic hepatitis B virus (HBV) infection remains a major health burden and the main risk
factor for the development of hepatocellular carcinoma worldwide. However, HBV is not …

Background and Aims Hepatitis delta virus (HDV) infection is associated with fast
progression to liver cirrhosis and liver complications. Previous studies have, however, been …

Hepatitis D is caused by infection with hepatitis D virus (HDV), a defective RNA virus that
requires the obligatory helper function of hepatitis B virus (HBV) for its in vivo transmission …